| ¿µ¹® | protein | ÇÑ±Û | ´Ü¹éÁú |
|---|---|---|---|
| ¼³¸í | ź¼Ò, ¼ö¼Ò, »ê¼Ò, Áú¼Ò, ȲÀ» ÇÔÀ¯Çϰí ÀÖ´Â À¯±âÈÇÕ¹°·Î, ¸ðµç ¼¼Æ÷ÀÇ ¿øÇüÁúÀ» ÀÌ·ç°í ÀÖ´Â ±âº» ±¸¼º¹°ÁúÀÌ´Ù. ´Ü¹éÁúÀº ±× ´ÜÀ§ÀÎ ¾Æ¹Ì³ë»êµéÀÌ ÆéƼµå°áÇÕ¿¡ ÀÇÇØ °áÇյǾî ÀÖÀ¸¸ç, º¸Åë 20°³ÀÇ ¾Æ¹Ì³ë»êµéÀÌ ´Ù¸¥ ¼ø¼¿Í Á¶¼ºÀ» °¡Áö°í ¹è¿µÇ¾î, µ¶Æ¯ÇÑ ÇϳªÀÇ ´Ü¹éÁúÀ» Çü¼ºÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | nuclear medicine | ÇÑ±Û | ÇÙÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼ºÀ» ¶ì´Â ÇÙ¹°ÁúÀ» ÀÌ¿ëÇÏ¿© ÀÇÇп¡ ÀÀ¿ëÇÏ´Â Çй®. ´ë°³ ÀÎü¿¡ Å« ÇØ°¡ ¾ø´Â ¹æ»ç¼±¹°ÁúÀ» »ç¿ëÇϸç, ¹Ý°¨±â°¡ ª¾Æ »ç¿ëÈÄ¿¡µµ Å« ÇØ°¡ ¾ø´Ù. ÀÌ·± ÇÙÀÇÇÐÀû ¹°ÁúÀ» ÀÌ¿ëÇÑ ÇÙÀÇÇÐÀû Áø´ÜÀÇ °¡Àå Å« ÀåÁ¡Àº »ýü³»¿¡¼ ÀϾ´Â ±× ±â°üÀÇ ½ÇÁ¦ÀûÀÎ ±â´ÉÀ» ¾Ë¾Æº¼ ¼ö ÀÖ´Ù´Â µ¥ ÀÖ´Ù. ÈçÈ÷ Á¢ÇÏ´Â X-¼±À» ÀÌ¿ëÇÑ Áø´Ü¹æ¹ýÀº ´ÜÁö ±× ¼ø°£¸¸ÀÇ ¿µ»óÀ» Á¢ÇÏ¿© ½ÇÁ¦·Î º¸ÀÌ´Â ºÎÀ§°¡ ¾ó¸¶³ª ±â´ÉÀ» ¼öÇàÇÏ´ÂÁö ¾Ë ¼ö ¾ø´Â ´ÜÁ¡ÀÌ ÀÖÀ¸³ª, ÇÙÀÇÇп¡¼´Â ½ÇÁ¦ÀûÀÎ ±â´ÉÀÇ Á¤µµ¿¡ µû¶ó ¿µ»óÀÌ ³ª¿À°Ô µÇ¹Ç·Î ±â´ÉÆÇº°¿¡ ¾ÆÁÖ À¯¸®ÇÏ´Ù. ÇÏÁö¸¸, Á¤È®ÇÑ ÆÇº°·ÂÀÌ ÀÖ´Â ¿µ»óÀ» ¾ò±â¿¡´Â ºÎÁ·ÇÏ´Ù. ¶ÇÇÑ ÇÙÀÇÇÐÀº Áø´Ü¿ÜÀÇ Ä¡·á¿¡µµ »ç¿ëµÇ´Âµ¥, ¿¹¸¦ µé¾î °©»ó»ùÁ¾¾çÀÇ °æ¿ì ¿©·¯ °÷¿¡ ÀÌ¹Ì ÀüÀ̰¡ µÇ¾î ÀÖÀ» °æ¿ì ¹æ»ç¼±ÇÙÁ¾À» ÀÌ¿ëÇÏ¿© ´Ù¸¥ °÷¿¡ Å« ºÎÀÛ¿ë¾øÀÌ Ä¡·á°¡ °¡´ÉÇÏ´Ù. |
||
| ¿µ¹® | nuclear magnetic resonance(NMR) | ÇÑ±Û | ÇÙÀÚ±â°ø¸í |
|---|---|---|---|
| ¼³¸í | ´Ù¸¥ ¸»·Î MRI=Magnetic Resonance Imaging ÀÚ±â°ø¸í¿µ»óÀ̶ó°íµµ ÇÑ´Ù. ÀÎüÀÇ Àå±â³ª, º´ÀûÀÎ ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇÏ´Â ¹æ»ç¼±ÇÐÀûÀÎ °Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í ÀÖ´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT=computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× ÇØ»óµµ°¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é(plane)¿¡¼ »ç¶÷À» ´ÜÃþ½ÃÄÑ º¼ ¼ö ÀÖ´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀÚÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í ÀÖ´Â ÁßȯÀÚ µî¿¡¼´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ¶³¾îÁö´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | rheumatoid factor | ÇÑ±Û | ·ù¸¶Æ¼½º ÀÎÀÚ |
|---|---|---|---|
| ¼³¸í | IgGÀÇ FcºÎÀ§¿¡ ÀÖ´Â Ç׿ø°áÁ¤ÀÎÀÚ¿¡ ´ëÇÑ Ç×ü·Î¼ ÀüÇüÀûÀÎ ¶Ç´Â È®½ÇÇÑ ·ù¸¶Æ¼½º°üÀý¿°(rheumatoid arthritis) ȯÀÚÀÇ 80%¿¡¼ ¹ß°ßµÈ´Ù. ·ù¸¶Æ¼½º ÀÎÀÚ´Â IgM, IgG, IgAÁß Çϳª°¡ µÉ ¼ö ÀÖÀ¸³ª ÁÖ·Î IgMÀÌ´Ù. ¼Ò¾Æ·ù¸¶Æ¼½º°üÀý¿°(juvenile rheumatoid arthritis: ¼Ò¾Æ±â¿¡ ¹ß»ýÇÏ´Â ·ù¸¶Æ¼½º°üÀý¿°)À» ºñ·ÔÇÑ, ´Ù¸¥ °áÇÕÁ¶Á÷º´À̳ª °¨¿°º´¿¡µµ ³ªÅ¸³¯ ¼ö ÀÖ´Ù |
||
| ¿µ¹® | growth factor | ÇÑ±Û | ¼ºÀåÀÎÀÚ |
|---|---|---|---|
| ¼³¸í | ¼¼Æ÷ÀÇ ºÐÈ ¹× ¼ºÀå¿¡ °ü¿©ÇÏ´Â ´Ü¹éÁú. ¼ºÀåÀÎÀÚ´Â Á¤»ó ¼¼Æ÷Áֱ⿡ ÇʼöÀûÀ̱⠶§¹®¿¡ µ¿¹°ÀÇ »ý¸í¿¡ Áß´ëÇÑ ¿ä¼Ò°¡ µÈ´Ù. ¹«¾ùº¸´Ùµµ ¼ºÀåÀÎÀڴ žÆÀÇ ¹ßÀ°À» Á¶Á¤Çϰí Á¶Á÷ÀÇ À¯Áö ¹× º¸¼ö¿¡ Áß´ëÇÑ ¿ªÇÒÀ» Çϸç, Ç÷±¸ÀÇ »ý¼ºÀ» ÀÚ±ØÇÑ´Ù. ¶ÇÇÑ ¾ÏÀÇ ÁøÇà°úÁ¤¿¡µµ °ü¿©ÇÑ´Ù. |
||
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
|---|---|
| EF | ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e... |
| PF | pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid... |
| NF | nafcillin; National Formulary; nephritic factor; neurofibromatosis; neurofilament; neutral fraction;... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| nuclear VV | nuclear volume |
|---|---|
| ANF | Anti-nuclear factor |
| GCNF | Germ Cell Nuclear Factor |
| HNF1 | Hepatic Nuclear Factor 1 |
| HNF4 | Hepatic nuclear factor 4 |
IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡
| nuclear factor 1 | See: CTF. (18 Nov 1997) |
|---|---|
| Nuclear actin binding protein | <molecular biology> Nuclear protein, dimer of 34 kD subunits. Binds actin with Kd of around 25M. (18 Nov 1997) |
| animal protein factor | <biochemistry> Member of the water soluble B vitamin group, important in the proper function of the nervous system and important in proper carbohydrate, protein and fat metabolism. (27 Sep 1997) |
| protein factor | The factor (6.25) by which the nitrogen content of a protein is multiplied to give the amount of protein. (05 Mar 2000) |
| insulin-like growth-factor binding protein 1 | One of the six homologous proteins that specifically bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits igf binding to cell surface receptors and thereby inhibits igf-mediated mitogenic and cell metabolic actions. (proc soc exp biol med 1993;204(1):4-29) (12 Dec 1998) |
| insulin-like growth factor-binding protein 2 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like growth factor binding protein 3 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin like growth-factor-binding protein 4 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like growth-factor-binding-protein 5 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| insulin-like-growth-factor-binding protein 6 | One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level. (12 Dec 1998) |
| epidermal growth factor receptor protein-tyrosine kinase | <enzyme> The catalytic protein-tyrosine kinase domain found on the cytoplasmic beta-portion of epidermal growth factor receptor. Registry number: EC 2.7.1.- (12 Dec 1998) |
| receptors, cytoplasmic and nuclear | Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands. (12 Dec 1998) |
| Remak's nuclear division | <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa. (18 Nov 1997) |
| Pelger-Huet nuclear anomaly | Congenital inhibition of lobulation in the nuclei of neutrophilic leukocytes; most cells present band or bilobulate appearance, and only an occasional cell is trilobed; it is not associated with disease, but may be confused with leukocyte "shift to left"; autosomal dominant inheritance. (05 Mar 2000) |
| ribonucleoproteins, small nuclear | Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end. (12 Dec 1998) |
Synonyms : ILF2 Protein, NF45 Protein
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|